What is it about?

Cardiac troponin I (cTnI) is a reliable marker to diagnose acute myocardial infarction, but the pathophysiological explanation for the increase in cTnI levels in patients with acute ischemic stroke (IS) remains unknown. To overcome this question, we aimed to compare serum cTnI levels in acute coronary syndrome (ACS) concomitant with and without stroke. By doing like this, we thought that we could demonstrate the effect of stroke on TrpI level.

Featured Image

Why is it important?

We found that abnormal troponin levels were more likely to be due to cardiac causes than cerebral ones in this first study evaluating the cTnI levels in patients with ACS concomitant with acute IS. The severity of IS, lesion location in the anterior circulation and higher troponin levels were associated with mortality.

Read the Original

This page is a summary of: Is Troponin really a reliable marker in patients with acute ischemic stroke?, December 2018, De Gruyter,
DOI: 10.2478/rjim-2018-0016.
You can read the full text:

Read

Contributors

The following have contributed to this page